Category:
Prophylactic Biological Products
A fixed-dose combination tablet containing Candesartan Cilexetil (CAS 138402-75-6) and Hydrochlorothiazide (CAS 58-93-5). The formula is C33H34N6O6·C7H8N2O4S2. Core synthesis involves esterification of candesartan with cilexetil followed by granulation.
Contraindicated in pregnancy and severe renal impairment. Store below 25°C in dry conditions to prevent hydrolysis. Handle active ingredients with respiratory protection protocols.